Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Chongqing Zhifei Biological Products Co., Ltd.
  6. Summary
    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

(300122)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
142.6 140 140.86 146.47 146.62 Last
13750750 12549690 12998750 11790150 8830187 Volume
-2.42% -1.82% +0.61% +3.98% +0.10% Change
Estimated financial data (e)
Sales 2021 27 536 M 4 280 M 4 280 M
Net income 2021 5 502 M 855 M 855 M
Net cash position 2021 2 777 M 432 M 432 M
P/E ratio 2021 38,8x
Yield 2021 0,59%
Sales 2022 35 842 M 5 571 M 5 571 M
Net income 2022 7 865 M 1 222 M 1 222 M
Net cash position 2022 8 960 M 1 393 M 1 393 M
P/E ratio 2022 28,7x
Yield 2022 0,72%
Capitalization 235 B 36 457 M 36 461 M
EV / Sales 2021 8,42x
EV / Sales 2022 6,30x
Nbr of Employees 3 380
Free-Float 14,7%
More Financials
Company
Chongqing Zhifei Biological Products Co., Ltd. specializes in the research and development of vaccines for human use. The products include, in particular, bacterial vaccines for the prevention of meningitis, tuberculosis, rabies and influenza. 
Sector
Pharmaceuticals
Calendar
10/29Earnings Release
More about the company
Ratings of Chongqing Zhifei Biological Products Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
10/07CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Zhifei's COVID-19 Vaccine Wins Emergency-Use Approv..
MT
09/22Zhifei-Biol Approves Election of Chen Xujiang and Gong Tao as Independent Directors
CI
09/20SPACE : in Talks to Invest in China's Anhui Province
MT
08/29Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
CI
08/27CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China's Zhifei says unit's COVID shot shows 81.76% ..
RE
08/02Chongqing Zhifei Biological Products Co., Ltd. Proposes Final Cash Dividend on A Shares..
CI
07/18CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Zhifei Biological's COVID-19 Vaccine Retains Effica..
MT
06/28Are Chinese COVID-19 shots effective against the Delta variant?
RE
06/11Chongqing Zhifei Biological Products Co., Ltd. Approves 2020 Profit Distribution Plan
CI
06/09China to study using CanSinoBIO COVID shots as a booster
RE
05/06Shares of China vaccine makers slump on U.S. waiver support
RE
04/20Chongqing Zhifei Biological Products Co., Ltd. Proposes Final Dividend for the Year 202..
CI
04/19Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Q..
CI
04/19CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China trials mixing of CanSinoBIO's and Zhifei Long..
RE
03/15CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China IMCAS's COVID-19 vaccine obtained emergency u..
RE
More news
News in other languages on CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
10/07Le vaccin COVID-19 de Zhifei obtient une autorisation d'utilisation d'urgence en Indoné..
09/20Space Group en pourparlers pour investir dans la province chinoise d'Anhui
05/06MÄRKTE ASIEN/Tokio sehr fest - Chin. Impfstoffhersteller stürzen ab
05/06MÄRKTE ASIEN/Japan sehr fest - Konflikt mit China belastet Sydney
04/19CHINA PRUEBA MEZCLAR VACUNAS COVID-1 : datos
More news
Chart CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Chongqing Zhifei Biological Products Co., Ltd. Technical Analysis Chart | 300122 | CNE100000V20 | MarketScreener
Technical analysis trends CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 146,62 CNY
Average target price 224,30 CNY
Spread / Average Target 53,0%
EPS Revisions
Managers and Directors
Ren Sheng Jiang Chairman & General Manager
Zhen Jing Li Chief Financial Officer & Director
Yu Qin Wu Chairman-Supervisory Board
Bao Kui Liu Independent Director
Gang Deng Independent Director
Sector and Competitors